News

Latest News:

mc2_news-image-icon-07

MC2 Biotek successfully completes plaque psoriasis study

POSTED: May 1, 2015

MC2 Biotek has received positive results from a plaque psoriasis study comparing MC2-01 PAD™ Cream (fixed dose combination of Betamethasone dipropionate/calcipotriene) to vehicle, monads, Taclonex Ointment and Taclonex Topical Suspension.

Data ...

READ FULL ARTICLE >

Upcoming Events:

February 28th, 2022

MC2 exposure at PCMA Business Forum 2022

READ MORE >

August 11th, 2021

MC2 Therapeutics is proud to support National Psoriasis Action Month

READ MORE >

July 23, 2021

MC2 Therapeutics supports World Sjögren’s Day

READ MORE >